BSE filing, BSE: 543346. Summary written from the filing by ALFA Finder's alert engine.
Aashka Hospitals Ltd: key numbers
- Share price
- ₹97.95
- Market cap
- ₹229.2 Cr
- Revenue (annual)
- ₹23.01 Cr
- Net profit (annual)
- ₹3.34 Cr
- P/E (TTM)
- 68.7×Sector 52.0×
- Promoter holding
- 61.34%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aashka Hospitals Ltd
All →Koura Fine Diamond Jewelry H1 FY27 Results: Net Profit ₹3.1 Cr, Up 675.0% YoY
Koura Fine Diamond Jewelry Ltd reported revenue from operations of ₹63.8 Cr (+6.3% YoY) and net profit of ₹3.1 Cr (+675.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹3.1 Cr · +675.0% YoY
Aashka Hospitals Price Movement Clarification
Aashka Hospitals clarified that the recent significant movement in its share price is purely market-driven. The company is unaware of any specific reason for this movement.
Aashka Hospitals Annual General Meeting
Aashka Hospitals Ltd held its 14th Annual General Meeting on 24 September 2026. The meeting transacted ordinary and special business resolutions as per the notice.
Aashka Hospitals Annual Report
Aashka Hospitals has submitted its Annual Report for the financial year 2025-26, pursuant to Regulation 34 of the SEBI LODR Regulations.
Aashka Hospitals Annual General Meeting
Aashka Hospitals Ltd has issued a notice for its 14th Annual General Meeting scheduled for September 24, 2026. Shareholders will consider accounts and special resolutions.
Aashka Hospitals Board Meeting Outcome
Aashka Hospitals Ltd. board re-appointed Mr. Bipinchandra D. Shah as Chairman and Managing Director. The company also decided not to incorporate a proposed subsidiary.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr